BRIXCELL LIFESCIENCES PVT LTD

Albendazole IP

Broad-spectrum benzimidazole anthelmintic API for tablet and suspension formulations targeting systemic parasitic infections. Sourced in IP-grade micronised powder from WHO-GMP certified facilities.

Ambroxol Hydrochloride IP

Mucoactive expectorant API for oral liquid, tablet, and inhalation formulations in respiratory tract management. Supplied in IP/EP grade with assured dissolution and particle size specifications.

Amoxicillin Trihydrate IP

Core penicillin-class antibiotic API supplied as compactable trihydrate powder for capsule and suspension manufacture. Available in standard and compacted direct-compression grades.

Ampicillin Trihydrate IP (Compacted)

Compacted ampicillin trihydrate optimised for direct compression tablet manufacture meeting IP pharmacopoeial standards. Preferred for high-volume oral antibiotic production lines.

Artemether IP

Lipid-soluble artemisinin derivative used in antimalarial fixed-dose combination tablets and oral capsules. Strictly controlled IP-grade API with COA documentation for regulated export markets.

Atorvastatin Calcium IP

HMG-CoA reductase inhibitor API for cholesterol management tablet formulations. Supplied in IP-grade crystalline form with strict impurity profile and polymorph consistency.

Atorvastatin Calcium USP

HMG-CoA reductase inhibitor meeting USP monograph specifications for FDA-regulated markets. Ideal for high-potency tablet manufacture with controlled particle size distribution.

Azithromycin Amine (Free Base)

Macrolide antibiotic free base form used as an intermediate in azithromycin salt and formulation manufacture. Traded for downstream conversion and custom pharmaceutical synthesis.

Azithromycin Dihydrate IP

Semisynthetic macrolide antibiotic in dihydrate form for tablet, capsule, and paediatric suspension formulations. Compliant with IP standards with verified microbiological purity.

Caffeine Anhydrous BP

Xanthine stimulant and analgesic adjuvant in anhydrous crystalline form to BP pharmacopoeial specifications. Used in analgesic combinations, energy supplements, and neonatal apnoea treatment.

Caffeine Anhydrous IP

Anhydrous caffeine meeting Indian Pharmacopoeia specifications for domestic and export pharmaceutical formulations. Supplied in food, pharmaceutical, and research grades.

Cefixime Miconized

Third-generation oral cephalosporin API in micronised particle size for enhanced bioavailability in oral suspensions and tablets. Micronisation ensures consistent dissolution performance in finished dosage forms.

Cefixime Trihydrate IP

Trihydrate form of cefixime for tablet and oral suspension manufacture, compliant with IP specifications. Widely used in paediatric and adult antibiotic formulations for regulated and emerging markets.

Cefixim Trihydrate Compacted IP / USP

Compacted cefixime trihydrate optimised for direct compression tabletting processes. Dual pharmacopoeial compliance (IP/USP) supports both domestic and US-regulated market supply.

Cefoperazone Sodium IP

Broad-spectrum injectable cephalosporin sodium salt API, sterile-grade, for IV/IM preparation manufacture. Supplied with endotoxin testing and sterility documentation for injectable manufacturing.

Cefotaxime Sodium (Sterile)

Sterile-grade third-generation cephalosporin API for lyophilised injectable vial production. Supplied with validated sterility and endotoxin clearance data for hospital and critical care formulations.

Cefpodoxime Proxetil

Orally active prodrug ester of cefpodoxime used in tablet and dry powder suspension formulations. Traded in pharma-grade with confirmed polymorphic form and particle size distribution.

Ceftriaxone IP

Broad-spectrum parenteral cephalosporin API for injectable formulation manufacture. Core product for hospital and export-market antibiotic supply chains across regulated territories.

Ceftriaxone Sodium Sterile IP

Sterile sodium salt form of ceftriaxone for lyophilised injectable vial manufacture. Full sterility and endotoxin testing documentation provided for regulated injectable manufacturing.

Ceftriaxone Sodium USP

Ceftriaxone sodium compliant with USP monograph specifications for FDA-regulated injection formulations. Preferred for North American and export injectable product lines.

Chloramphenicol IP

Broad-spectrum antibiotic API in crystalline form for ophthalmic, otic, and oral formulations. Traded with documented bioburden and residual solvent profiles per IP pharmacopoeia.

L/N-type dual calcium channel blocker API used in antihypertensive tablet formulations. Traded in fine crystalline grade for precision dose tablet manufacturing.

Ciprofloxacin Hydrochloride IP

Fluoroquinolone antibiotic hydrochloride salt API for oral tablet and IV infusion formulations. IP-grade with controlled impurity profile for domestic and export pharmaceutical manufacture.

Citicoline Sodium (CDP-Choline)

Neuroprotective pharmaceutical API used in tablet, sachet, and injectable formulations. Sourced in high-purity pharmaceutical grade with confirmed spectroscopic identity.

Clindamycin Phosphate

Water-soluble phosphate ester prodrug of clindamycin used in injectable and topical formulations. Supplied in sterile and non-sterile API grades with full impurity and assay documentation.

Cyanocobalamin (Vitamin B12)

Cobalamin vitamin API for injectable, tablet, and nutraceutical formulations. Traded in pharmaceutical grade with assured cyanocobalamin content and residual solvent compliance.

Enoxaparin Sodium

Low-molecular-weight heparin (LMWH) biopolymer for prefilled syringe anticoagulant formulations. Supplied with anti-Xa activity assay and molecular weight distribution documentation.

Erythromycin Stearate IP

Stearate salt of erythromycin for oral tablet formulations with improved acid stability and palatability. IP-grade API with documented microbiological potency and residual solvent profile.

Etoricoxib IP/IH

Selective COX-2 inhibitor API for anti-inflammatory and analgesic tablet formulations. Supplied in IP and institutional hospital grades with polymorph-controlled crystalline form.

Fluconazole IP

Triazole antifungal API for oral capsule, tablet, and injectable formulations. IP pharmacopoeial grade with confirmed optical purity and dissolution performance for standard formulations.

Fluconazole USP

Fluconazole API meeting USP monograph specifications for FDA-regulated antifungal formulations. High-purity grade preferred for US and regulated international export product lines.

Gabapentin IP

Anticonvulsant and neuropathic pain API for capsule and tablet formulations. Supplied in IP grade with controlled particle size and impurity profile for precision-dose manufacture.

Ph.Eur

Gemcitabine Hydrochloride Ph.Eur

Glimepiride IP

Sulphonylurea antidiabetic API for oral tablet formulations managing type 2 diabetes. Supplied in IP grade with confirmed polymorphic form, particle size, and dissolution performance.

Heparin Sodium IP-MEGA

High-potency biological heparin sodium sourced from porcine intestinal mucosa. Anti-Xa and anti-IIa activity certified, suitable for large-volume parenteral and injection formulations.

Non-steroidal anti-inflammatory propionic acid derivative meeting British Pharmacopoeia specifications. Used in tablet, gel, and suspension formulations for analgesic and anti-inflammatory applications.

Ibuprofen API compliant with Indian Pharmacopoeia standards for tablet, capsule, and suspension manufacture. High-purity grade with documented chiral and impurity profile for regulated market supply.

Itraconazole IP

Triazole antifungal API for oral capsule and pellet-based formulations. Supplied in micronised and amorphous grades to optimise bioavailability in finished antifungal dosage forms.

Ketoconazole IP

Imidazole antifungal API for topical cream, shampoo, and oral tablet formulations. Traded in IP grade with confirmed polymorphic form and documented impurity control.

Lumefantrine USP

Arylaminoalcohol antimalarial API used in combination with artemether for oral antimalarial tablet formulations. USP-grade with confirmed purity and particle size specifications for coformulation.

Mefenamic Acid IP

Anthranilic acid NSAID API for oral tablet and capsule formulations. Supplied in IP-grade crystalline form with controlled particle size and impurity profile for standard and paediatric dosage forms.

Mesalamine USP

5-Aminosalicylic acid API for oral delayed-release and rectal formulations in inflammatory bowel disease management. USP-grade with confirmed mesalamine content and residual solvent documentation.

Mesalazine IP

IP-grade 5-aminosalicylic acid for domestic Indian market oral and rectal formulations targeting inflammatory bowel disease. Full pharmacopoeial compliance with COA and stability documentation.

Metformin HCL IP

Biguanide antidiabetic API as hydrochloride salt for tablet formulations. High-throughput IP-grade with controlled particle size for direct compression and granulation manufacturing.

Free base form of metformin meeting IP pharmacopoeial specifications for antidiabetic oral tablet manufacture. Traded alongside HCl salt form for flexible formulation compatibility.

Methylcobalamin IP

Bioactive methyl form of Vitamin B12 for neurological tablet, injectable, and nutraceutical formulations. Pharmaceutical-grade API with confirmed methylcobalamin potency and light-sensitivity specifications.

Montelukast Sodium IP

Leukotriene receptor antagonist API for oral tablet and granule formulations in asthma and allergic rhinitis management. Amorphous sodium salt with confirmed residual solvent and polymorph documentation.

Pantoprazole Sodium Sterile IP

Proton pump inhibitor sodium sesquihydrate API in sterile grade for lyophilised injectable vial manufacture. Endotoxin-tested with sterility documentation for hospital-grade IV formulations.

Pantoprazole Sodium USP

Pantoprazole sodium meeting USP pharmacopoeial monograph for oral delayed-release tablet and IV formulations. Preferred for FDA-regulated and North American export pharmaceutical supply.

Paracetamol IP

Acetaminophen analgesic/antipyretic API in IP-grade crystalline and granular forms for tablet, capsule, and syrup formulations. High-volume traded API with full COA and dissolution clearance.

Piperacillin + Tazobactam IP Sterile

Sterile-grade combination of piperacillin sodium and tazobactam sodium for injectable formulation manufacture. IP-compliant sterile API blend with endotoxin testing and sterility documentation.

Piperacillin Sodium + Tazobactam Sodium Inj USP

USP-grade sterile piperacillin-tazobactam combination API for US-regulated injectable formulation. Supplied with full endotoxin and sterility clearance for large-volume antibiotic injectable production.

Ph.Eur

Pregabalin EP

Pregabalin (IP)

IP pharmacopoeial–grade pregabalin for domestic and export capsule and oral solution formulations. Supplied with confirmed chiral purity, particle size, and dissolution performance data.

Benzimidazole proton pump inhibitor API for oral enteric-coated tablet formulations. Traded in refined crystalline grade with documented impurity profile and polymorph consistency.

Rosuvastatin Calcium IP

HMG-CoA reductase inhibitor calcium salt API for oral tablet formulations. IP-grade with confirmed polymorphic form and low-dose tablet suitability for statin therapy supply.

Serratiopeptidase IP

Bacterial serine protease enzyme API in enteric-form used in anti-inflammatory tablet formulations. Traded in IP-grade with confirmed enzymatic potency (SPU/mg) per pharmacopoeial standards.

High-intensity sweetener (600× sucrose) for pharmaceutical and nutraceutical formulations requiring calorie-free sweetening. Supplied in standard purity grade for direct blending in oral dosage forms.

Sucralose Sweetener

Consumer and formulation-grade sucralose blend suitable for oral liquid, chewable, and powder dosage forms. Provides consistent taste masking in paediatric and diabetic-friendly formulations.

Sucralose-Techno

Technical-grade sucralose for large-volume pharmaceutical manufacturing processes. Optimised for blendability and flowability in high-throughput granulation and direct compression operations.

Sulbactam Sodium Sterile IP/USP

Beta-lactamase inhibitor sterile sodium salt API, dual pharmacopoeial–compliant (IP/USP) for injectable combination antibiotic formulations. Full sterility and endotoxin clearance documentation provided.

Tazobactam Sodium IP

Beta-lactamase inhibitor API in sodium salt form for injectable combination antibiotic formulation manufacture. IP-grade with both sterile and non-sterile grades available for flexible supply.

Can’t find what you need?
Our sourcing desk can help.

We maintain extended sourcing networks beyond the listed catalog. Send us your COA requirements, target grade, and order quantity — our regulatory trade team will respond within 12 business hours.